HCAIX-IN-19

HCAIX-IN-19 is a potent and selective sulfonamide-based inhibitor of carbonic anhydrase IX (hCAIX), with a KI of 6.2 nM and 117-fold selectivity over hCAI. This compound is a valuable research tool for investigating the role of hCAIX in hypoxic tumor environments, applicable in both in vitro and in vivo cancer biology studies.